Noninvasive Models to Predict Liver Fibrosis in Patients with Chronic Hepatitis B: A Study from Turkey

AuthorPinar Korkmazen
AuthorNese Demirturken
AuthorAyse Batırelen
AuthorAhmet Cem Yardimcien
AuthorUnal Cagiren
AuthorSalih Atakan Nemlien
AuthorFatime Korkmazen
AuthorFusun Zeynep Akcamen
AuthorHuseyin Sener Baruten
AuthorBurcu Bayraken
AuthorFaruk Karakecilien
AuthorHuseyin Tarakcien
AuthorZerrin Yulugkuralen
AuthorEsma Yukselen
AuthorNazlım Aktug Demiren
AuthorOnur Uralen
AuthorSua Sumeren
AuthorRezan Harmanen
AuthorAyten Kadanalien
AuthorSinan Ozturken
AuthorSila Cetin Akhanen
AuthorNecla Eren Tuleken
AuthorDerya Ketenen
AuthorAlper Seneren
AuthorBilgehan Aygenen
AuthorAysel Kocagul Celikbasen
AuthorFatma Yilmaz Karadagen
AuthorGule Aydinen
AuthorEyup Arslanen
AuthorCahide Sacligilen
AuthorGulfem Akengin Ocalen
AuthorAlpaslan Tanogluen
AuthorAsim Ulcayen
AuthorErgenekon Karagozen
AuthorNese Saltogluen
AuthorFatma Sırmatelen
AuthorHayrettin Akdenizen
AuthorAynur Aynıogluen
AuthorSelcan Arslan Ozelen
AuthorSelmin Dirgen Caylaken
AuthorIlhami Celiken
AuthorYesim Alpayen
AuthorZehra Bestepe Dursunen
AuthorMuhammed Bekcibasien
AuthorGunay Tuncer Ertemen
AuthorArzu Tiglien
AuthorElif Sargin Altunoken
AuthorKemal Avsaren
AuthorKaya Sueren
AuthorMurat Sayanen
OrcidIlhami Celik [0000-0002-2604-3776]en
Issued Date2017-12-31en
AbstractBackground: Many noninvasive methods, including aspartate amino transaminase (AST)/alanine amino transaminase (ALT) ratio (AAR), AST-to-platelet ratio index (APRI), Bonacini cirrhosis discriminant score (CDS), fibrosis-4 (FIB4) index, and age-platelet index (API), have been described to determine the stage of hepatic fibrosis. However, these methods are developed for patients with chronic hepatitis C (CHC) and produce conflicting results in the prediction of liver fibrosis in patients with chronic hepatitis B (CHB). Objectives: The aim of this study was to evaluate the relationship between 7 noninvasive models, including AAR, APRI, CDS, API, FIB-4, neutrophil-to-lymphocyte ratio (NLR), and red cell distribution width (RDW)-to-platelet ratio (RPR) in patients with CHB. Methods: The study population included all patients with CHB, undergoing liver biopsy to determine HBsAg and HBV DNA positivity in more than 6 months. Results: A total of 2520 treatment-naive CHB patients from 40 different centers were included in the study. In total, 62.6% of the patients were male, and the mean age was 40.60 ± 12.34 years (minimum, 18 years; maximum, 77 years). The Ishak fibrosis score was ≥ 3 in 29.8% of the patients, indicating significant fibrosis. The mean API, APRI, CDS, NLR, FIB4, and RPR scores in the noninvasive models were significantly different between the groups with significant and low fibrosis (P < 0.05). All the noninvasive models (API, APRI, AAR, CDS, NLR, RPR, and FIB4) were found to be significant in the discrimination of cirrhosis (P < 0.05). In the multiple logistic regression analysis, CDS, albumin, alkaline phosphatase (ALP), total bilirubin, neutrophil count, NLR, mean platelet volume (MPV), and FIB4 were independent indices for cirrhosis. Conclusions: In the present study, the role of noninvasive tests in the prediction of liver fibrosis stage and cirrhosis was evaluated in a large cohort of CHB patients. Overall, noninvasive models are gradually becoming more promising. Accordingly, the need for liver biopsy can be reduced with a combination of noninvasive methods in the future.en
DOIhttps://doi.org/10.5812/hepatmon.60266en
KeywordChronic Hepatitis Ben
KeywordLiveren
KeywordFibrosisen
KeywordNoninvasive Modelsen
PublisherBrieflandsen
TitleNoninvasive Models to Predict Liver Fibrosis in Patients with Chronic Hepatitis B: A Study from Turkeyen
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
hepatmon-17-12-60266.pdf
Size:
305.8 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF